Also, we confirmed that RBM5-AS1 could be upregulated by RUNX2 overexpression (Fig. 2H), and RUNX2 expression could be induced by hypoxia (Fig. 2I) in breast cancer cells. Here, RBM5 is linked to breast carcinoma.